AliveAndKickn, Haworth, NJ Videos

Today is #nationalprevivorday A Previvor is someone that is diagnosed with a hereditary cancer gene but hasn't yet had cancer. Listen to what it is like to be a Previvor. #HereditaryCancerWeek

Join us at the 2022 Blue Genes Bash NYC Thursday, December 8th for the chance to bid on two tickets plus parking for the December 11th game between the NY Giants and the Philadelphia Eagles. This game could decide who wins the division! You must be present at the Blue Genes Bash to bid. Register to attend now https://www.aliveandkickn.org/bgb2022

Blue Genes Bash Honorees
Join AliveAndKickn in NYC, Thursday, December 8th 6:30-9:30pm for the 2022 Blue Genes Bash to hear from our incredible honorees. Register here, https://www.aliveandkickn.org/bgb2022 ⁠ Dr. Vilar-Sanchez is Associate Professor (Tenured) and Deputy Chair of the Department of Cancer Prevention at MD Anderson Cancer Center. He is a physician-scientist and a medical oncologist by training with clinical expertise in hereditary colorectal cancer syndromes (mainly Lynch Syndrome and Familial Adenomatous Polyposis - FAP) and colorectal medical oncology. Dr. Vilar-Sanchez’s research efforts are focused in developing novel cancer interception strategies including vaccines and chemopreventive agents, and early detection methods for patients at high-risk for colorectal cancer development. ⁠ ⁠ Jean Hannah Edelstein first learned about Lynch syndrome in 2010, when her father and her paternal aunt were both diagnosed with the MSH2 gene. As with many other Lynch families, the diagnosis resolved the question of why so many of them had early-onset colon and other cancers over several generations.

Join AliveAndKickn in NYC, Thursday, December 8th 6:30-9:30pm for the 2022 Blue Genes Bash to support the valuable programming for the Lynch syndrome patient community. Register now, https://www.aliveandkickn.org/bgb2022

Join AliveAndKickn in NYC, Thursday, December 8th 6:30-9:30pm for the 2022 Blue Genes Bash to hear from our incredible honorees. Register here, https://www.aliveandkickn.org/bgb2022 ⁠ Dr. Vilar-Sanchez is Associate Professor (Tenured) and Deputy Chair of the Department of Cancer Prevention at MD Anderson Cancer Center. He is a physician-scientist and a medical oncologist by training with clinical expertise in hereditary colorectal cancer syndromes (mainly Lynch Syndrome and Familial Adenomatous Polyposis - FAP) and colorectal medical oncology. Dr. Vilar-Sanchez’s research efforts are focused in developing novel cancer interception strategies including vaccines and chemopreventive agents, and early detection methods for patients at high-risk for colorectal cancer development. ⁠ ⁠ Jean Hannah Edelstein first learned about Lynch syndrome in 2010, when her father and her paternal aunt were both diagnosed with the MSH2 gene. As with many other Lynch families, the diagnosis resolved the question of why so many of them had early-onset colon and other cancers over several generations.

2022 Blue Genes Bash Join AliveAndKickn, hear from incredible honorees and support important Lynch syndrome programming. Register now, https://www.aliveandkickn.org/bgb2022

Join AliveAndKickn in NYC, Thursday, December 8th 6:30-9:30pm for the 2022 Blue Genes Bash to hear from our incredible honorees. Register here, https://www.aliveandkickn.org/bgb2022 ⁠ Dr. Vilar-Sanchez is Associate Professor (Tenured) and Deputy Chair of the Department of Cancer Prevention at MD Anderson Cancer Center. He is a physician-scientist and a medical oncologist by training with clinical expertise in hereditary colorectal cancer syndromes (mainly Lynch Syndrome and Familial Adenomatous Polyposis - FAP) and colorectal medical oncology. Dr. Vilar-Sanchez’s research efforts are focused in developing novel cancer interception strategies including vaccines and chemopreventive agents, and early detection methods for patients at high-risk for colorectal cancer development. ⁠ ⁠ Jean Hannah Edelstein first learned about Lynch syndrome in 2010, when her father and her paternal aunt were both diagnosed with the MSH2 gene. As with many other Lynch families, the diagnosis resolved the question of why so many of them had early-onset colon and other cancers over several generations.

Join AliveAndKickn in NYC, Thursday, December 8th 6:30-9:30pm for the 2022 Blue Genes Bash to support the valuable programming for the Lynch syndrome patient community. Register now, https://www.aliveandkickn.org/bgb2022

2022 Blue Genes Bash
Join AliveAndKickn, hear from incredible honorees and support important Lynch syndrome programming. Register now, https://www.aliveandkickn.org/bgb2022

What does it mean to be a "Previvor"? Join us on June 14th to learn how to manage a Lynch syndrome diagnosis when you have never had cancer. Why is this diagnosis so important? Learn how to be proactive. See how others are managing this. Register now https://bit.ly/3t57PZu

Join us this evening. Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare, Tuesday, May 24th, 6:00pm ET In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Registration here, https://bit.ly/3NsMTUX

Next up in the Virtual Community Discussion Series Is a conversation about "Coping with a Lynch diagnosis" moderating by Cathryn Koptiuch, MS, CGC, Cancer Genetic Counselor, Intermountain Healthcare In partnership with @coloncancercoalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees. Register here, https://bit.ly/3NsMTUX

Join us tonight for a conversation about "Genetic Testing for Lynch" moderating by Maureen Mork, MS, CGC, Senior Genetic Counselor, The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics⁠ ⁠ In partnership with Colon Cancer Coalition, each session will feature a Living with Lynch patient video followed by live discussions around each topic. Scheduled from March through August 2022, we will engage a moderator to facilitate conversation with patients, medical professionals and other experts, patient advocates, and online attendees.⁠ ⁠ Registration https://bit.ly/3NsMTUX